Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-03 Magrath George Chief Executive Officer Sale −28,258 $3.90 $110K 2,010,636
2026-10-23 SCHACHLE JOSEPH K Chief Operating Officer Sale −4,767 $3.57 $17K 286,673
2026-10-23 YERXA BENJAMIN R President Sale −7,669 $3.55 $27K 696,437
2026-10-23 YERXA BENJAMIN R President Sale −25,520 $3.53 $90K 670,917
2026-10-23 Gagnon Robert E. Chief Financial Officer Sale 10b5-1 −14,000 $3.55 $50K 542,375
2026-10-23 Magrath George Chief Executive Officer Sale −9,591 $3.59 $34K 2,038,894
2026-09-30 Foundation Fighting Blindness Retinal Degeneration Fund Director Sale −556,000 $4.96 $2.8M 3,236,171
2026-09-09 Magrath George Chief Executive Officer Exercise or conversion +392,157 $1.15 $451K 2,124,026
2026-09-09 Magrath George Chief Executive Officer Shares withheld for taxes −75,541 $5.97 $451K 2,048,485
2026-09-09 Magrath George Chief Executive Officer Exercise or conversion · Warrant (right to buy) −392,157 0
2026-09-08 Gallagher Cam Director Exercise or conversion +784,314 $1.15 $902K 2,800,111
2026-09-08 Gallagher Cam Director Exercise or conversion · Warrant (right to buy) −784,314 0
2026-09-03 Gagnon Robert E. Chief Financial Officer Sale −28,000 $4.54 $127K 556,375
2026-07-23 YERXA BENJAMIN R President Sale −7,429 $2.97 $22K 704,106
2026-07-23 SCHACHLE JOSEPH K Chief Operating Officer Sale −4,644 $2.94 $14K 291,440
2026-07-23 Magrath George Chief Executive Officer Sale −9,475 $2.95 $28K 1,731,869
2026-07-23 Gagnon Robert E. Chief Financial Officer Sale −7,783 $2.95 $23K 584,375
2026-05-18 Foundation Fighting Blindness Retinal Degeneration Fund Director Sale −1,700,000 $4.35 $7.4M 3,792,171
2026-04-23 YERXA BENJAMIN R President Sale −7,470 $5.24 $39K 711,535
2026-04-23 SCHACHLE JOSEPH K Chief Operating Officer Sale −4,697 $5.22 $25K 296,084

Page 1 of 22 · 437 trades